CONVENIA VETERINARY

Страна: Израел

Език: английски

Източник: Ministry of Health

Активна съставка:

CEFOVICIN AS SODIUM SALT

Предлага се от:

ZOETIS ISRAEL HOLDING B.V., ISRAEL

Лекарствена форма:

POWDER AND SOLVENT FOR SOLUTION FOR INJECTION

Композиция:

CEFOVICIN AS SODIUM SALT 80 MG/DOSE

Начин на приложение:

S.C

Вид предписание :

Required

Произведено от:

HAUPT PHARMA LATINA S.R.L, ITALY

Терапевтични показания:

Dogs : For the treatment of skin and soft tissue infections including pyoderma wounds and abscesses associated with Staphylococcus intermedius beta-haemolytic streptococci escherichia coli and/or pasteurella multocida. For the treatment of urinary tract infections associated with Escherichia coli and/or Proteus spp.As adjunctive treatment to mechanical or surgical periodontal therapy of severe infections of the gingival and periodontal tissues associated with Porphyromonas spp. and Prevotella spp. Cats : For the treatment of skin and soft tissue abscesses and wounds associated with pasteurella multocida fusobacterium spp. bacteroides spp. prevotella oralis beta-haemolytic streptococci and/or staphylococcus intermedius. For the treatment of urinary tract infections associated with escherichia coli.

Дата Оторизация:

2020-11-30

Листовка

Component
Pharma Code
GTIN
CR Number
Description
Artwork Code
Supplier
Market
Perigord Nº
Colours
TEXT SIZE
The BODY text
on this A/W is at:
Dimensions
SKU N
o
Drawing Number
Date:
Time:
Proof Nº
Tel: [phone]
Web: www.perigord-as.com
E-mail: [e-mail]
GLOBAL EXTERNAL SUPPLY
51752269
HAUPT PHARMA LATINA SRL
Israel
721005
Leaflet
XXXIXX
N/A
200013610
N/A
7.0 pt
03
13 : 08
Black
Profile
INS CONVENIA SPO 10ML ISR
30 MAR 2023
PAGE 1 OF 6
Dimensions
140 x 229 mm
Folded Dimensions
120 x 209 mm
Drawing Number
FIBIN_140X229X3 32GR
VETERINARY MEDICINE PACKAGE LEAFLET
This medicine is dispensed with a veterinarian’s
prescription only
For use in animals only
1. NAME, FORM AND STRENGTH OF THE VETERINARY
MEDICINE
Convenia Veterinary
2.
ACTIVE INGREDIENTS
Each vial of lyophilised powder contains: cefovecin
(as sodium salt) 852 mg.
After reconstitution according to the instructions, the
solution for injection contains: cefovecin as sodium
salt 80 mg/ml.
The list of inactive ingredients is provided in section 13.
3.
WHAT IS THIS MEDICINE INTENDED FOR
For use only for the following infections requiring
prolonged
treatment.
The
antimicrobial
activity
of
Convenia following a single administration lasts for
up to 14 days.
Dogs:
For the treatment of skin and soft tissue infections
including
pyoderma,
wounds
and
abscesses
associated
with
_Staphylococcus _
_intermedius_,
β
-haemolytic
_streptococci, _
_Escherichia _
_coli_
and/or
_Pasteurella multocida_.
For the treatment of urinary tract infections associated
with _Escherichia coli_ and/or _Proteus_ spp.
As adjunctive treatment to mechanical or surgical
periodontal
therapy
of
severe
infections
of
the
gingival
and
periodontal
tissues
associated
with
_Porphyromonas_ spp. and _Prevotella_ spp.
Cats:
For the treatment of skin and soft tissue abscesses
and
wounds
associated
with
_Pasteurella _
_multocida_,
_Fusobacterium_
spp.,
_Bacteroides_
spp.,
_Prevotella oralis_, β-haemolytic _ streptococci_ and/or
_Staphylococcus intermedius_.
For the treatment of

Данни за продукта

Convenia Veterinary LPD CC 12.04.2022
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Convenia Veterinary
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE:
Each vial of lyophilised powder contains 852 mg cefovecin (as sodium
salt)
When reconstituted according to label instruction, the solution for
injection contains 80.0 mg/ml
cefovecin (as sodium salt)
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Powder and solvent for solution for injection.
The powder is off-white to yellow and the diluent (solvent) is a
clear, colourless liquid.
4.
CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs and Cats.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For use only for the following infections which require prolonged
treatment. The antimicrobial activity
of Convenia following a single injection lasts for up to 14 days.
Dogs:
For the treatment of skin and soft tissue infections including
pyoderma wounds and abscesses
associated with Staphylococcus intermedius beta-haemolytic
streptococci escherichia coli and/or
pasteurella multocida.
For the treatment of urinary tract infections associated with
Escherichia coli and/or Proteus spp.
As adjunctive treatment to mechanical or surgical periodontal therapy
of severe infections of the
gingival and periodontal tissues associated with Porphyromonas spp.
and Prevotella spp.
Cats:
For the treatment of skin and soft tissue abscesses and wounds
associated with pasteurella
multocida fusobacterium spp. bacteroides spp. prevotella oralis
beta-haemolytic streptococci
and/or staphylococcus intermedius.
For the treatment of urinary tract infections associated with
escherichia coli.
4.3 CONTRAINDICATIONS
Do not use in cases of hypersensitivity to cephalosporin or penicillin
antibiotics.
Do not use in small herbivores (including guinea pigs and rabbits).
Do not use in dogs and cats less than 8 weeks old.
Convenia Veterinary LPD CC 12.04.2022
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5 SPECIAL PRECAUTIONS FOR USE
Special precautions for use in anima